SPHK1 and ovarian cancer: It has been observed that hypoxia-induced SPHK1 expression and its downstream S1P signaling promote ovarian cancer progression, and elevated expression levels of SPHK1 or S1P are sensitive to the cytotoxic effects of metformin (Hart et al., 2019).